Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Incyte (INCY) and Vertex Pharmaceuticals (VRTX). But which of these two stocks presents investors with the ...

This growth model looks for low book-to-market stocks that exhibit characteristics associated with sustained future growth. VERTEX PHARMACEUTICALS INC (VRTX) is a large-cap value stock in the ...

This growth model looks for low book-to-market stocks that exhibit characteristics associated with sustained future growth. VERTEX PHARMACEUTICALS INC (VRTX) is a large-cap value stock in the ...

Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. By comparison, VRTX has a P/B of 7.67.

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Incyte (INCY) and Vertex Pharmaceuticals (VRTX). But which of these two stocks presents investors with the ...

Vertex Pharmaceuticals (VRTX) ended the recent trading session ... outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988.

The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. For comparison, VRTX has a P/B of 6.80.